drug
bendamustine hydrochloride
Marketedupdated 3mo agoby Eagle Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
DLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying bendamustine hydrochloride
- phase1Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
- phase2Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- phase2Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
- phase3A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 26, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (79)
- Jul 29, 2042formulationUS 11707450
- Jul 29, 2042formulationUS 11844784
- Jul 29, 2042formulationUS 12208086
- Jul 29, 2042formulationUS 12419867
- Mar 15, 2033method-of-use (U-1971)US 10052385
- Mar 15, 2033method-of-use (U-1542)US 9000021
- Mar 15, 2033method-of-use (U-1542)US 9034908
- Mar 15, 2033method-of-use (U-1542)US 9144568
- Mar 15, 2033method-of-use (U-1971)US 9572887
- Mar 15, 2033method-of-use (U-1972)US 9579384
- Mar 15, 2033method-of-use (U-1971)US 9597397
- Mar 15, 2033method-of-use (U-1971)US 9597398
- Mar 15, 2033method-of-use (U-1971)US 9597399
- Aug 11, 2031formulationUS 86097075.0y
- Aug 11, 2031formulationUS 86097075.0y
- Apr 26, 2031patentUS 8436190*PED4.7y
- Apr 26, 2031patentUS 8436190*PED4.7y
- Jan 28, 2031formulationUS 100105334.4y
- Jan 28, 2031formulationUS 100105334.4y
- Jan 28, 2031formulationUS 111034834.4y
- Jan 28, 2031formulationUS 111034834.4y
- Jan 28, 2031method-of-use (U-1971)US 118447834.4y
- Jan 28, 2031method-of-use (U-1972)US 118447834.4y
- Jan 28, 2031formulationUS 118722144.4y
- Jan 28, 2031formulationUS 118722144.4y
- Jan 28, 2031formulationUS 121382484.4y
- Jan 28, 2031formulationUS 121382484.4y
- Jan 28, 2031formulationUS 123502574.4y
- Jan 28, 2031formulationUS 123502574.4y
- Jan 28, 2031formulationUS 92658314.4y
- Jan 28, 2031formulationUS 92658314.4y
- Jan 28, 2031formulationUS 95727964.4y
- Jan 28, 2031formulationUS 95727964.4y
- Jan 28, 2031method-of-use (U-1972)US 95727974.4y
- Jan 28, 2031method-of-use (U-1971)US 95727974.4y
- Oct 26, 2030formulationUS 84361904.2y
- Oct 26, 2030formulationUS 84361904.2y
- Mar 23, 2030patentUS 8344006*PED3.6y
- Mar 23, 2030patentUS 8344006*PED3.6y
- Sep 26, 2029patentUS 8445524*PED3.1y
- Sep 26, 2029patentUS 8445524*PED3.1y
- Sep 26, 2029patentUS 8445524*PED3.1y
- Sep 26, 2029patentUS 8445524*PED3.1y
- Sep 26, 2029patentUS 8669279*PED3.1y
- Sep 26, 2029patentUS 8669279*PED3.1y
- Sep 26, 2029patentUS 8883836*PED3.1y
- Sep 26, 2029patentUS 8883836*PED3.1y
- Sep 26, 2029patentUS 9533955*PED3.1y
- Sep 26, 2029patentUS 9533955*PED3.1y
- Sep 23, 2029formulationUS 83440063.1y
- Sep 23, 2029formulationUS 83440063.1y
- Mar 26, 2029compositionUS 84455242.6y
- Mar 26, 2029compositionUS 84455242.6y
- Mar 26, 2029compositionUS 84455242.6y
- Mar 26, 2029compositionUS 84455242.6y
- Mar 26, 2029formulationUS 86692792.6y
- Mar 26, 2029formulationUS 86692792.6y
- Mar 26, 2029formulationUS 88838362.6y
- Mar 26, 2029formulationUS 88838362.6y
- Mar 26, 2029formulationUS 95339552.6y
- Mar 26, 2029formulationUS 95339552.6y
- Jul 12, 2026patentUS 8609863*PED
- Jul 12, 2026patentUS 8609863*PED
- Jul 12, 2026patentUS 8791270*PED
- Jul 12, 2026patentUS 8791270*PED
- Jul 12, 2026patentUS 8791270*PED
- Jul 12, 2026patentUS 8791270*PED
- Jul 12, 2026patentUS 8895756*PED
- Jul 12, 2026patentUS 8895756*PED
- Jan 12, 2026formulationUS 8609863
- Jan 12, 2026formulationUS 8609863
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8791270
- Jan 12, 2026formulationUS 8895756
- Jan 12, 2026formulationUS 8895756
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 33m ago
Found something off?
comments(0)
5-min edit window · permanent after that